Ticker Details
Vera Therapeutics, Inc.
IPO Date:	May 14, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.92B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.79 | 3.34%
Avg Daily Range (30 D):	$0.91 | 2.25%
Avg Daily Range (90 D):	$1.13 | 2.61%

Institutional Daily Volume
Avg Daily Volume:	.58M
Avg Daily Volume (30 D):	1.1M
Avg Daily Volume (90 D):	1.09M

Trade Size
Avg Trade Size (Sh.):	70
Avg Trade Size (Sh.) (30 D):	63
Avg Trade Size (Sh.) (90 D):	59

Institutional Trades
Total Institutional Trades:	2,158
Avg Institutional Trade:	$2.37M
Avg Institutional Trade (30 D):	$3.31M
Avg Institutional Trade (90 D):	$2.98M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.83M
Avg Closing Trade (30 D):	$8.02M
Avg Closing Trade (90 D):	$6.88M
Avg Closing Volume:	122.66K

News

Apr 6, 2026 @ 5:00 PM Idiopathic Membranous Nephropathy Market is Predic... Source: Delveinsight

Mar 13, 2026 @ 2:36 PM This Fund Bet $200 Million on a Biotech Stock Up 5... Source: Jonathan Ponciano

Mar 5, 2026 @ 2:00 PM Vera Therapeutics Appoints Christopher Hite to Boa... Source: Not Specified

Dec 10, 2025 @ 1:57 AM Vera Therapeutics Announces Pricing of Public Offe... Source: Vera Therapeutics

Nov 21, 2025 @ 3:50 PM BK Virus Infection Market Trends, Strategies and B... Source: Researchandmarkets.Com

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-4.66	$-1.39	$-4.66
Diluted EPS	$-4.66	$-1.39	$-4.66
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-299.62M	$-91.1M	$-299.62M
Operating Income / Loss	$-315.47M	$-94.21M	$-315.47M
Cost of Revenue
Net Cash Flow	$262.08M	$296.95M	$262.08M
PE Ratio